TH1601007114A - "Loba Platin Crystal Preparation method And pharmaceutical use " - Google Patents

"Loba Platin Crystal Preparation method And pharmaceutical use "

Info

Publication number
TH1601007114A
TH1601007114A TH1601007114A TH1601007114A TH1601007114A TH 1601007114 A TH1601007114 A TH 1601007114A TH 1601007114 A TH1601007114 A TH 1601007114A TH 1601007114 A TH1601007114 A TH 1601007114A TH 1601007114 A TH1601007114 A TH 1601007114A
Authority
TH
Thailand
Prior art keywords
pharmaceutical use
crystal preparation
loba
platin
compound
Prior art date
Application number
TH1601007114A
Other languages
Thai (th)
Inventor
โด ชิหลิง
ซุย ดงหู่
จาง เซ็งกุย
Original Assignee
นายมนูญ ช่างชำนิ
นางสาวสุวดี ศิริชีพชัยยันต์
Filing date
Publication date
Application filed by นายมนูญ ช่างชำนิ, นางสาวสุวดี ศิริชีพชัยยันต์ filed Critical นายมนูญ ช่างชำนิ
Publication of TH1601007114A publication Critical patent/TH1601007114A/en

Links

Claims (2)

: ข้อถือสิทธิ์ (ข้อที่หนึ่ง) ซึ่งจะปรากฏบนหน้าประกาศโฆษณา : ------12/02/2561------(OCR) หน้า 1 ของจำนวน 5 หน้า ข้อถึอสิทธิ: Privileges (number one) which will appear on the advertisement page: ------ 12/02/2018 ------ (OCR) Page 1 of the number 5 pages. 1. ผลึกสารประกอบโลบาปลาตินมีลักษณะเฉพาะที่ว่ามีผลึกนาลองโมเลกุลอยู่ในโครงสร้างผลึก1. Lobaplatin compound crystals are characterized by having molecular crystals in their crystal structure. 2. ผลึกสารประกอบโลบาปลาดินตามข้อถือสิทธิข้อ 1 ที่ซึ่งรูปผลึกของสารประกอบโลบาปลาดิน ดังกล่าวคือรูปผลึก A และมีพีคการเลียวเบนที่ค่า 20ประมาณ 11.04, 12.32, 12.61, 13.85, 15.14,15.55, 16.68, 17.67, 17.86, 19.03, 20.06, 21.00, 22.68, 22.92, 23.76, 25.39, 25.58, 26.37, 26.77, 27.00, 27.71, 28.13, 29.71, 31.42, 31.94, 32.89, 34.29, 34.60, 36.10, 36.93, 37.66,แท็ก : สิทธิบัตรยา2. Lobapladin compound crystal according to claim 1, where the crystal form of lobapladin compound These are A-crystalline forms and have a deflection peak of 20 approx. 11.04, 12.32, 12.61, 13.85, 15.14,15.55, 16.68, 17.67, 17.86, 19.03, 20.06, 21.00, 22.68, 22.92, 23.76, 25.39, 25.58. , 26.37, 26.77, 27.00, 27.71, 28.13, 29.71, 31.42, 31.94, 32.89, 34.29, 34.60, 36.10, 36.93, 37.66, Tag: drug patent.
TH1601007114A 2014-11-28 "Loba Platin Crystal Preparation method And pharmaceutical use " TH1601007114A (en)

Publications (1)

Publication Number Publication Date
TH1601007114A true TH1601007114A (en) 2019-10-07

Family

ID=

Similar Documents

Publication Publication Date Title
TH1601007114A (en) "Loba Platin Crystal Preparation method And pharmaceutical use "
TH1501003557A (en) "The use of 3-carboxy-N-ethyl-N, N-dimethyl propan-1-aluminum Or the pharmacologically acceptable salt of this substance in the treatment of atherosclerosis. "
TH1501003256A (en) Pharmaceutical constituents containing chloroprocaine - are the basis for their action. To be repeated in the spinal canal
TH1601001699A (en) Ceftholosen's solid form
TH1501005347A (en) S-Ketamine Hydrochloride Pharmaceutical Composition
TH1601006448A (en) Muscle atrophy inhibitors containing quercetin glycosides
TH1701002633A (en) Antigen-bound molecules made up of trymers of the TNF family ligand.
TH177127A (en) Stabilized insulin glulisine formulation
TH177286A (en) Steel plate
TH178566A (en) The stable constituents of the neuroactive peptides
TH162724A (en) Steel plate
TH178972A (en) Alkylated cyclodextrin composition And the process for preparing And using the same
TH1601004226A (en) Antibody molecules to PD-1 and their uses
TH175872A (en) The use of a mixture of salt and sugar in the production of drugs used to treat the syndrome Vaginal prolapse or mammalian colposerosis
TH1701003780A (en) Sulfonamides Pharmaceutical Composition
TH1601003237A (en)
TH178633A (en) Antibiotic composition
TH1701003406A (en) Pharmaceutical formulation of tropomieosin-related kinase inhibitors (TRK).
TH1601006489A (en) Pro-drak of 1,1 '- (1,6-dioxo-1,6-hexendaiyl) bis-D-proline.
TH1701002548A (en) Long-acting pharmaceutical constituents for hepatitis C
TH182826A (en) Thyazine compounds and their use for medical purposes
TH175588A (en) KZ144 modified endolysin sequence
TH1701002664A (en) Therapeutic combination for the treatment of drug-resistant bacterial infections.
TH178578A (en) Vaccine composition against dengue virus
TH1501005024A (en) Pharmaceutical constituents for the treatment of fungal infections.